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1. Introduction 
An abdominal aortic aneurysm (AAA) is a balloon-like bulge or weakened area in the wall 
of aorta. The larger the aneurysm becomes, the more likely it will rupture which could lead 
to life-threatening bleeding, and potentially death.  Surgical repair of the aneurysm prior to 
rupture is often life-saving. This can be performed either as an open procedure or 
endoluminal with a stent graft. 
The management of abdominal aortic aneurysms (AAA), whether discovered incidentally 
on imaging studies or by an astute physician on physical exam, continues to have a huge 
impact on clinical practice and the lives of patients. Through research, the art of medicine, 
and extensive patient counseling, surveillance versus elective repair continues to be a 
dynamic and changing science. When indications for elective repair arise, such as worsening 
symptoms, increased or rapid growth of the aneurysm, or a diameter greater than 5 cm is 
present, a decision regarding surgical options are brought to the forefront.  
Open AAA repair was the sole form of surgical treatment until endoluminal repair was 
introduced into practice in 1991. Much research has been publicized supporting the 
decreased recovery time and the short term morbidity of endoluminal repair compared to 
open repair. However, some authors suggest that the benefits of endoluminal repair with 
respect to mortality rate achieved in the early postoperative period disappear in the long 
term recovery scheme (Zeebregts et al., 2004).  
The controversies surrounding endoluminal repair of AAA have involved defining the ideal 
candidate based on risk factor stratification and overcoming challenging anatomy of the 
aorta. According to Steinmetz et al, “the ideal candidate for endovascular repair [is] still to 
be defined” (Steinmetz et al., 2010).  However, with new improvements to detect 
complications intraoperatively, and advances in technology to prevent/treat migration and 
endoleaks, the quest to determine the ideal candidate may be unnecessary.  The presence of 
an intraoperative endoleak may increase the likelihood of an endoleak being seen during the 
follow-up period, but not necessarily the likelihood of an additional reintervention or 
operative procedure (Sampaio et al., 2009). The ultimate goal is to enable the applicability of 
this elective, minimally invasive approach to prevent the catastrophic event of a ruptured 
AAA to be widespread. 
Endoluminal AAA repair obviates the three major physiologic insults associated with open 
repair laparotomy, aortic cross-clamping, and ischemia reperfusion injury (Halak  et al., 
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2007). In addition, the majority of the patients undergoing endovascular aneurysmal repair 
(EVAR) had regional anesthesia, thus reducing perioperative morbidity associated with 
sedative medication utilization in patients with multiple co-morbidities. Furthermore, this 
study determined that the duration of operation was shorter, blood loss was significantly 
less, and there was decreased hospital stay in the EVAR verses open repair (Zeebregts et al., 
2004).  
For these reasons, uncertainty remains regarding the long-term effectiveness of endoluminal 
AAA repair and its proper role in the management of patients with AAA. In particular, 
debate continues as to whether or not younger patients at good risk should be treated in this 
fashion or whether small aneurysms should be treated at an earlier interval in a more 
aggressive approach with stent grafts. To examine outcome data that might impact 
decisions on these issues, we reviewed a 12-year experience with 807 primary AAA 
endografts to determine the frequency of beneficial outcome and the incidence and causes of 
clinical failures of endovascular repair. 
2. Materials and methods  
Over 12 years ending in 2010, 807 patients underwent endovascular repair of infrarenal 
AAA. Five devices were used over this period: Ancure (Guidant, Menlo Park, Calif), 
AneuRx (Medtronic/AVE, Santa Rosa, Calif), Excluder (W. L. Gore, Flagstaff, Ariz), 
Quantum (Cordis Corp., NJ) and Zenith (Cook Inc, Bloomington, Ind). All procedures were 
performed in a Hybrid operating room environment, where Radiologic imaging was 
performed with a high-quality, fixed C-arm fluoroscopic unit with digital imaging and road 
mapping capability on a radiolucent operating room table with movable top. 
Patient selection for the procedure and decisions regarding devices used were based on 
radiologic imaging studies. Preoperative helical computed tomography (CT) was performed 
with 3 mm axial reconstruction. If initial measurements and morphology of the aneurysm 
were favorable for endovascular repair, multiplanar contrast angiography was performed 
with a special catheter with radiopaque markers at 1-cm intervals (Cook, Inc) to allow for 
precise length measurements and assessment of renal and pelvic anatomy, particularly in 
regard to device access and deployment. Intravascular ultrasound studies were also 
performed when measurements were deemed inaccurate on the basis of these studies, or in 
the presence of suspected renal or iliac occlusive disease. Except in patients with 
contraindications to contrast material, postoperative CT scans included non-contrast-
enhanced, contrast- enhanced, and 3-minute to 5-minute delayed post-contrast-enhanced 
images.  
Outcome was assessed with physical examination, lower extremity arterial studies, plain 
abdominal radiography, and computed tomography at discharge, at 1, 6, and 12 months 
postoperatively, and annually thereafter.  
Data were collected from a review of operative imaging reports and physician chart notes. 
Any significant discrepancy between these two data sources prompted an interrogation of 
the source imaging studies. Outcome reporting adhered to the standards outlined by the Ad 
Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for 
Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS) (Chaikof et al., 
2002) 
Clinical failures of endovascular AAA repair were defined as the following events: peri-
procedural death (<30 days), late (>30 days) or late conversion of endograft repair to 
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conventional open surgical repair, increase in maximal AAA sac diameter of 5 mm or 
greater after endograft exclusion, and AAA rupture after endoluminal aneurysm treatment.  
All perioperative deaths occurred as a result of aneurysm rupture or after a primary or 
secondary procedure directed at treating the aneurysm or complications thereof.  
Secondary procedures were defined as any subsequent procedure (exclusive of diagnostic 
angiography), whether percutaneous or open surgical, related to aneurysm repair or 
complications thereof. While procedures performed because of wound complications were 
tabulated for descriptive purposes, they were excluded from statistical analysis.  
Endoleak was classified on the basis of serial imaging studies. CT findings, although most 
influential, composed only one factor. Presumed type I leak observed on CT scans was 
invariably followed up with angiographic confirmation. A leak was considered type II when 
the contrast collection was posterior or at the orifice of the inferior mesenteric artery. Type II 
and IV endoleaks noted only on an intraoperative or predischarge imaging study were 
excluded from analysis. Leakage through enlarged suture holes or fabric tears was classified 
as type III endoleak, as were defects related to separation of modular components. An 
endoleak was suspected to be type III when it directly abutted the graft fabric or was 
associated with obvious disunion of components; half of these were confirmed at 
angiography or at open surgical conversion.  
Migration was defined with clinical and radiographic parameters, as suggested by the 
SVS/AAVS document on endovascular reporting standards (Chaikof et al., 2002).  Migration 
included caudal movement of the proximal attachment site or cranial movement of a distal 
attachment site. A device was considered to have migrated when at least 1 cm of movement 
was noted relative to anatomic landmarks, when the patient experienced symptoms, or when 
an intervention was undertaken to treat migration, irrespective of distance.  
Aneurysm shrinkage or growth was determined with a pre-procedural CT scan performed 3 
months or less before the date of the procedure as the baseline. A predischarge imaging study 
was used as the reference scan when a preoperative study was not available. Size 
measurements were made on the CT scan with the greatest minor sac dimension on any axial 
image. Aneurysm shrinkage was defined as decrease of 5 mm or more in the minor dimension 
of the sac; enlargement was defined as increase of 5 mm or more in this dimension.  
The individual clinician responsible for the patient’s determined the need for secondary 
procedures. Certain clinical events mandated intervention, including post-implant 
aneurysm rupture or symptomatic graft limb occlusion. Most, however, were less 
catastrophic, and the need for secondary intervention was subjective. Basic treatment 
paradigms were, however, standard at the institution.  
Treatment of types I and III endoleaks was always recommended. Type II endoleak was 
treated when the aneurysm sac was observed to enlarge over time. As well, patients with 
type II leak received treatment when the aneurysm failed to contract despite observation for 
more than 12 months after the initial endovascular repair. Type II leak in patients with a 
shrinking sac was not treated. Device migration was treated when it was associated with a 
type I leak or when the remaining length of sealing was deemed inadequate, usually when 
reduced to less than 10 mm. 
3. Results 
Eighty percent of treated patients were men. The mean age was 72.6 years (range, 44 to 87 
years), and the mean AAA sac maximal diameter was 5.7 cm (range, 4.1 to 10.2 cm). Risk 
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factors and co-morbidities were typical of patients undergoing vascular surgical procedures. 
Patient demographics are displayed in Table 1. 
In the 12-year experience, one or more clinical failures, as defined previously, were observed 
in a total of 74 patients (9.2%). Because some patients had more than one adverse event 
denoting failure, the number of such events exceeded the number of patients sustaining 
them.  
 
Patient Demographics (n = 807) Mean/n (range/%) 
Age (years)  72.6 (range 44-87) 
Gender  
Male   646 (80) 
Female   161 (20) 
Average sac diameter (cm)  5.7 (range 4.1-10.2) 
Comorbidities  
HTN  480 (59) 
CAD  451 (56) 
Tobacco use  407 (50) 
Diabetes  159 (20) 
Hyperlipidemia  255 (32) 
COPD  201 (25) 
Renal insufficiency  79 (10) 
Notes: HTN = Hypertension, CAD = coronary artery disease; COPD = chronic obstructive 
pulmonary disease 
Table 1. Patient demographics 
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3.1 Operative deaths 
Eight periprocedural deaths (1%) occurred in the total of 807 AAA stent graft repairs (Table 
2.) One death occurred as the result of an acute myocardial infarction on day 3 after implant 
in a patient with a symptomatic AAA at high risk with known extensive coronary artery 
disease not amenable to surgical or catheter-based repair. This mortality occurred early in 
our experience after the procedure had been prolonged with a series of vascular access, 
device introduction, and deployment difficulties. Although eventually a technically 
successful implant was achieved, in retrospect, more prompt conversion to standard open 
repair would likely have resulted in a more favorable outcome.  
Diffuse atheroembolization was the most common cause of death in our series after 
endoluminal stent graft placement. Uniformly, the 4 patients afflicted by this complication 
expired secondary to severe multisystem organ failure. All patients had significant 
thrombus burden within either the proximal landing zone or suprarenal aorta (or both).  The 
complication was seen irrespective of graft type or fixation mechanism. In each case the 
potential for this complication had been recognized preoperatively. However, endoluminal 
therapy was chosen for AAA repair due to patient/family demand (2 cases), hostile 
abdominal status for open repair (1 case), or severe concomitant pulmonary disease which 
precluded the likelihood of postoperative extubation (1 case).  In three cases the primary 
inciting event was the discovery of inoperable small bowel (2 cases) or colonic (1 case) 
ischemia.  All patients had arteriographic demonstration of proximal, branch vessel patency 
when the complication was initially suspected. But the distal vascular “pruning” was 
resistant to all attempts at pharmacologic rescue.  In the remaining case the insult was 
rendered to the parenchyma of a lone kidney. The family refused dialysis and withdrew 
supportive care 10 days after surgery.  
One sudden early death occurred at home 8 days after discharge and was presumed to be 
the result of rupture of a large symptomatic AAA. No evidence of a proximal attachment 
leak had been suspected on predischarge CT scanning, but the patient had a short, 
angulated proximal AAA neck and was high-risk for graft migration. We elected to 
schedule this patient for frequent surveillance for a period of several months. Although no 
autopsy was performed to confirm rupture, this seems the likely cause, as the patient had 
severe back and abdominal pain before collapse. 
Another patient became hypotensive in the hospital 12 hours after an endoluminal repair 
during which a persistent endoleak was evident at the distal fixation zone. The leak 
appeared resistant to all conventional means of resolution (ballooning, additional cuff, 
stents, etc) and it was elected to inject biologic glue into the coaptation zone. Emergency CT 
scan showed complete thrombsis of the entire pelvic vasculature, emanating from the 
affected internal iliac artery in the landing zone. Limb and lower extremity ischemia ensued 
soon thereafter. Despite operative exploration and fem-fem bypass, the patient died of renal 
and pulmonary insufficiency after a prolonged and complex 2-week postoperative course. In 
retrospect, more prompt conversion to standard open repair would likely have undoubtedly 
resulted in a more favorable outcome. 
The remaining early death occurred after an early complication of attempted sheath 
insertion for endograft implantation, resulting in external iliac rupture and severe 
retroperitoneal hemorrhage.  Attempt at open repair failed due to prolific calcification 
throughout the patient’s aorto-iliac system, confounding conventional attempts at vascular 
clamping or suture repair. 
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A common thread in most of these cases was technical complications occurring in patients 
who were elderly, fragile, and at high risk for perioperative morbidity. 
 
Cause n (%) 
MI after surgery 1 (0.1) 
Massive atheroemboli 4 (0.4) 
Died at home 8 days after discharge 1 (0.1) 
Limb /pelvic thrombosis-rhabdomyolysis 1 (0.1) 
Avulsion EIA 1(0.1) 
  
Notes: MI=myocardial infarction, EIA=external iliac artery 
Table 2. Perioperative deaths (30 days)  
3.2 Early conversions 
During the 12-year study period, twelve patients (1.5%) needed early conversion to open 
repair within the first 48 hours after the procedure. Successful endograft implantation was 
achieved in the remaining 795 patients, for an overall procedural technical success rate of 
98.5%. 
Two patients treated early in our experience had small, calcified iliac arteries that sustained 
severe traumatic injury during attempted passage of large-caliber stents or devices. In 
retrospect, these cases were examples of inappropriate judgments and poor patient 
selection, typical of grappling with a formidable “learning curve” associated with a new, 
paradigm-changing technology. One of the patients had a 360-degree twist in the limbs of 
an unsupported Ancure bifurcated device (Guidant, Santa Clara, Calif) that could not be 
corrected, requiring fem-fem bypass. Another patient needed immediate conversion when 
acute migration of the proximal attachment system occurred in a short and heavily calcified 
aortic neck, resulting in the endograft falling into the AAA sac. Seven patients required fem-
fem bypass for access site complications ranging from uncontrollable hemorrhage to 
occlusion, not amenable to conventional repair secondary to vessel fragility, small size, or 
calcification. The final patient in this subgroup had acute rupture of his aneurysm on 
postoperative day 8, as already described in the previous section detailing periprocedural 
deaths.  
3.3 Late conversions 
Nine patients (1.1%) needed late (30 days) conversion to standard open graft repair for a 
variety of clinical scenarios. Conversions were performed at a mean of 20 months after the 
original endograft procedure (range, 9 to 32 months).  
Six of nine conversions in our series were caused by AAA sac growth with demonstrated 
endoleak (“endotension”). Two endoluminal grafts needed late conversion as the result of 
graft infection. Both were presumed to be caused by septicemic seeding of the endoluminal 
device. Although these cases might conceivably be the result of primary endograft 
infections, this is much less likely in our opinion. One conversion in our series was caused 
by continued AAA sac growth without demonstrated endoleak. At the time of laparotomy 
and explantation, numerous small leaks were evident at the suture-fixation points of the 
stents to the graft. 
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As outlined above, conversion was necessary in seven patients because of continued AAA 
growth. Endoleak was present in all but one patient in this subgroup. One patient had a 
persistent proximal type 1 attachment leak, four had persistent type 2 leaks from lumbar 
arteries, and one patient an acute late type 3 endoleak caused by a fabric hole erosion in a 
Zenith endograft implanted 20 months previously. The patient had done well, with sac 
shrinkage and no demonstrable endoleak, up to the 6-month interval. The patient then was 
seen with sudden back pain, and CT scanning showed a type 3 leak with acute sac re-
expansion. Emergent open operation and repair proceeded uneventfully.  
One patient did well until 32 months after the original procedure when he was seen at an 
outside facility with a septic left ankle joint. The patient underwent treatment with drainage 
and antibiotics. Within several months, however, the patient returned again with bilateral 
septic hips and septic shoulder joint. Blood cultures grew methicillin-resistant 
Staphylococcus aureus. The patient again underwent treatment with drainage and 
antibiotics. Despite this, al psoas muscle abscess developed that was drained 
percutaneously. However, subsequent CT scans showed communication with the endograft 
and the area of abscess.  
Further, evidence of bone destruction developed of vertebral bodies lumbar 3 and 4. 
Subsequently, the patient underwent a staged procedure of axillobifemoral bypass grafting 
followed by removal of the infected endograft with radical debridement of vertebral body 
osteomyelitis. The patient was discharged from the hospital after a prolonged hospital 
course.  
One patient needed late conversion at 27 months for acute thrombosis of the entire 
endograft, resulting in severe lower extremity ischemia. Prior follow-up CT scans had 
shown good AAA exclusion, with sac shrinkage and no endoleak. However, distortion and 
slight kinking of the endograft limbs was noted and believed attributable to the 
morphologic sac changes caused by its shrinkage. The patient was asymptomatic with intact 
pulses, so observation and continued surveillance was elected. Presumably, limb kinking 
increased, resulting in thrombosis. Emergent axillobifemoral bypass grafting was 
performed, with a satisfactory result.  
3.4 Sac growth  
In the series, follow-up CT imaging revealed 82 patients with sac growth of the aneurysm of 
5 mm or greater, despite endoluminal repair of the AAA.  
All of these patients had at least 90 days of follow-up. Of the 82 patients, 64 thus far have 
undergone successful treatment with endovascular therapies. Further secondary 
interventions are planned for most of the remaining patients with AAA sac growth but had 
not yet been performed when the study period was terminated. Such secondary procedures 
included a variety of catheter-based therapies, including insertion of proximal or distal 
extender cuffs, branch or sac embolization, or related interventions as deemed appropriate 
with angiography or other diagnostic methods. None of the patients with sac growth are 
symptomatic, and no ruptures, thromboses, or conversions have occurred in this cohort.  
3.5 Ruptures 
During the 12-year experience, seven patients (0.9%) are believed to have had AAA rupture 
after their endoluminal repair. five patients, all with unproven but presumed rupture at 
home at varying intervals (5-17 months) after surgery and a sixth with post-discharge 
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rupture on postoperative day 5 have already been described previously in the sections 
detailing periprocedural deaths and early conversions.  
A final rupture occurred at 2 years after the original endovascular procedure. 
The patient had undergone three interval CT scans that had shown no leak and a decrease in 
maximal AAA diameter from 5 to 4.6 cm. Shortly after the most recent follow-up CT scan, 
the patient was seen acutely with abdominal and back pain. Emergency CT scan showed a 
large endoleak and acute re-expansion of the AAA sac to greater than the original 6-cm 
diameter, with an adjacent retroperitoneal hematoma. At emergency operation, acute 
detachment of the proximal stent attachment mechanism was found, with the distal 
endograft lying free in the AAA sac. We presumed the shrinking AAA sac wall had become 
atretic and ruptured when acutely repressurized. The patient survived operative conversion 
to open repair. After a prolonged hospitalization, the patient was discharged to a 
rehabilitation facility.  
Despite often extensive and emergent operations needed for late conversion of endovascular 
to open repairs, no deaths occurred as a result of such procedures in our series.  
3.6 Secondary reinterventions 
A variety of problems after endograft repair were identified at various intervals during 
clinical and radiologic postimplant follow-up surveillance. These included persistent 
primary endoleaks, late secondary leaks, instances of graft migration, kinking, or 
thrombosis, and other problems that were believed to threaten endoluminal repair and 
expose the patient to possible conversion or rupture or both. For this reason, reinterventions 
were believed necessary.  
During the 12-year study period, 81 patients (10%) needed a total of 109 secondary 
procedures. The vast majority of these were catheter-based reinterventions , including 
percutaneous angioplasty, pharmacologic lysis of limb thrombosis, insertion of additional 
vascular stents in native vessels, proximal or distal extensions of the original stent graft 
device, embolization of branch vessels or the AAA sac itself, or similar related procedures. 
These were judged clinically effective in correcting or eliminating the problem needing 
reintervention in 94% (n=76) of the 81 patients. Patients who underwent such success 
reinterventions were not classified as having clinical failures but rather as having assisted-
primary successes.  
4. Discussion  
This series summarizes the data from our 12-year experience with 807 patients with AAAs 
treated with endoluminal stent graft repair.  
Our results confirm an extensive number of reports from other centers that clearly 
document that endovascular AAA repair is safe and can be successfully performed in 
patients with suitable anatomy (Blum et al., 1997; Brewster et al., 1998; Brewster et al., 2003; 
Dillavou et al., 2006; May et al., 1998; Moore et al., 1999; Moore et al., 2001; Zarins et al., 
1999). 
The implant success in most centers, as in our series, is now approaching 99%. This and 
other outcome parameters are likely to further improve with newer generation devices, 
namely as such devices involve lower profile technology and the bulk of our complications 
stemmed from access challenges. In addition to low mortality and only a 1% early 
conversion rate, our results document quite effective treatment of the AAA relative to its 
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anticipated natural history, albeit with a relatively short 2.5-year mean follow-up period. 
The AAA has remained stable in size or actually diminished in maximal diameter in 92% of 
cases, and serious late problems, such as conversion to open repair and AAA rupture, 
remain infrequent. 
The mortality rate of our series was 1%. The less invasive characteristics of endoluminal 
repair are clearly reflected by this as well as the low morbidity and mortality rates reported 
in the aforementioned series. Although this rate is not significantly different from results 
from several high-volume single institution reports involving traditional open repair, we 
believe many of the patients in our series who underwent endoluminal repair were frail, 
high-risk patients, often with advanced cardiopulmonary problems or other comorbidities, 
who would very likely have had considerably higher mortality rates if treated with 
conventional open operation.  
This contention remains unproven, of course, because no truly randomized prospective 
studies exist in this regard. It is worthwhile emphasizing that most of the deaths in our 
series occurred after procedural challenges during the endovascular stent access, 
introduction or deployment. These difficulties invariably occurred in elderly, fragile patients 
with adverse and challenging anatomic features. We believe this underscores the need for 
careful patient selection and adherence to accepted anatomic selection criteria.  
The presence of endoleaks, defined as a failure to totally exclude the AAA from continued 
perfusion and pressurization, may be associated with the subsequent expansion of the 
aneurysm and possible rupture.  However, the patient is unaware of an endoleak and not 
really concerned unless an undesirable outcome results. Thus, endoleaks remain a potential 
concern, but we have not regarded these as a mode of clinical failure unless adverse 
sequelae, such as continued AAA enlargement, AAA rupture, or other problems, resulted. 
This position may be challenged by some who believe that any demonstrated endoleak is a 
criteria of failure. Indeed, the clinical significance of endoleak remains uncertain and poorly 
understood (Chuter et al., 2001; Makaroun et al., 1999; Matsumura & Moore, 1998; Steinmetz 
et al., 2004; Timaran et al., 2005). 
Two factors indendently favored an increased incidence of endoleak in our series:  advanced 
age and female gender. Increasing age may be associated with more complex anatomy, 
although none of the anatomic variables investigated were found to be predictive of 
endoleaks. The higher incidence of endoleak associated with female gender may be related 
to as yet undetermined factors, intrinsic to the aneurysm, to the vessel wall, or to the blood. 
In addition, the coagulation profile, on which we have no information in this study, may be 
a significant factor, especially with respect to type 2 endoleaks. Importantly, many 
authorities believe the most common variety of endoleak (type 2 retrograde branch leak) 
rarely causes clinical consequences, and several studies have shown poor correlation 
between endoleak and outcome. (Baum et al., 2002; Gilling-Smith et al., 2000; Jones et al., 
2007; Resch et al., 1998; Velazquez et al., 2000; Zarins et al., 2000). 
However, it should be acknowledged that almost all type III endoleaks will need some form 
of reintervention or conversion and that type I attachment leaks are well recognized as more 
hazardous in terms of AAA enlargement and rupture risk. Further, it should be noted that, 
in our series, all patients with AAA sac growth resulting in conversion to open repair did 
have some type of endoleak, including one patient with a type II branch leak alone, which 
was visualized at open repair. Our conclusion, that endoleak is not a desirable or benign 
phenomenon seems justified, but we do not regard its presence alone as reliable prognostic 
predictor or a clear-cut indicator of clinical failure of endoluminal repair.  
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Similarly, in our opinion, an indicator of clinical failure of endoluminal AAA repair should 
not be the need for limited secondary reinterventions on this patient population. As 
illustrated by our series in which a relatively modest 10% of patients needed secondary 
procedures, almost all catheter-based endovascular interventions rather than surgical 
procedures, the vast majority were believed clinically successful in correcting the presumed 
cause of sac growth or other clinical problems, thereby maintaining the integrity and success 
of the endograft repair. Similar success rates have been reported by other investigators with 
respect to secondary interventions (Dattilo et al., 2002; Giles et al., 2011; Hobo et al., 2006; 
Laheij et al., 2000; May et al., 2000). 
As long as successful endovascular treatment of their aneurysm can be maintained and 
major surgical repair avoided, we believe the concept of primary-assisted success, achieved 
by means of such limited re-interventions, is valid and well accepted by patients.  
Although our re-intervention rate was a 10%, our relatively short mean follow-up period of 
33 months must be recognized. In the large European collaborative registry (Eurostar) 
experience of more than 1000 patients followed for 12 or more months, 18% have needed 
secondary interventions at a mean follow-up interval of 20 months (Laheij et al., 2000). It 
appears reasonable to assume that secondary interventions will be necessary within this 
patient population at a cumulative rate of approximately 10-20% per year. Similar Eurostar 
data have emphasized the ongoing and cumulative incidence of both late conversions and 
aneurysm rupture, noting cumulative rates of approximately 2%/year for conversion to 
open repair and a rupture risk of approximately 1%/year (Harris et al., 2000). 
Application of this procedure has increased rapidly in many centers around the world, and 
many investigators now urge more widespread use. The less invasive nature of this 
approach, and the generally good and beneficial early results of treatment, clearly have 
made endovascular AAA repair an appealing, if not compelling, therapeutic alternative to 
many patients with AAA. Some regard it as the procedure of choice for all AAAs that are 
anatomically suitable and believe it is reasonable to use even in young patients at good risk. 
Other advocates urge prophylactic repair of small (5 cm) AAA, with the belief that the safer 
and less invasive treatment would justify earlier treatment and potentially improve long-
term outcomes (Becquemin et al., 2000; Holzenbein et al., 2001; Ouriel et al., 2003; 
Peppelenbosch et al., 2004; Zarins et al., 2006).  
Thoughtful concern in this regard should be considered, given that long-term effectiveness 
and durability of endovascular repair clearly appears to be less than that anticipated by 
most surgeons after standard open operative repair. This is supported by our results, as well 
as the mid-term results reported by other investigators. (Bush et al., 2001; Buth & Laheij, 
2000; Chaikof et al., 2009; Crawford et al., 1981; Hallett et al., 1997; Johnston, 1994). 
Although it must be acknowledged that conventional surgical repair is rarely subjected to 
the intense scrutiny and post-implant surveillance common to endovascular repair, 
nonetheless long-term effectiveness of endograft repair as we now know cannot match the 
late outcome and reliability of standard AAA operative repair, based on the finding of the 
aforementioned investigators.  
Theoretically, newer-generation, lower profile devices may improve endoluminal outcomes. 
Further, future device advances and improvements may reduce device structural failures 
and may enable the endoluminal grafts to better accommodate to morphologic AAA sac 
changes that have been recognized by many authorities and that contribute to late failures 
by causing endograft kinking, migration, component separation, and other adverse 
consequences. However, this remains to be established. Most series to date, including this 
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report, are dominated by results of earlier, first-generation endografts. (Beebe et al., 2001; 
Chaikof et al., 2009; Harris et al., 1999; Rutherford & Krupski, 2004). 
We believe the clinical implications of our study are several. First, endoluminal AAA repair 
has clearly been a major advance in the treatment of aortic aneurismal disease. Its safety, 
efficacy, feasablility and generally good early and mid-term results have been well shown in 
our series and many other published reports. It appears particularly advantageous to more 
elderly patients at high risk and patients with hostile abdominal characteristics, many of 
whom may have previously been denied repair. In such patients with suitable vascular 
anatomy for delivery and deployment, it is reasonable and appropriate in our opinion to 
consider endovascular repair the procedure of choice (Brewster, 2001; Dattilo et al., 2002; 
Visser et al., 2006). 
However, it should be recognized that the actual definition of “high-risk” remains debatable 
and not well defined in the literature. Further, endoluminal repair seems advantageous in 
patients with a “hostile” abdomen because of a variety of factors and also an appealing and 
likely beneficial option in patients with other unusual conditions that may cause technical 
difficulties and challenges for conventional open repair, such as para-anastomotic 
aneurysms after previous aortic surgery, AAA in the presence of a horseshoe kidney, and 
AAA in patients with prior renal transplants.  
Secondly, because of current concerns related to device structural stability and long-term 
reliability of this form of repair, in our opinion, more widespread use of endografts to repair 
small AAA cannot be supported (Finlayson et al., 1999). 
Similarly, because failure modes of endoluminal repair such as endoleak, graft migration, 
and other are much more frequent in patients with adverse anatomy, this procedure should 
not be used in a wonton fashion in patients who do not have well-defined appropriate 
aneurysmal anatomic features for potential rupture. This is particularly true in patients at 
very high risk because the need for conversion in these circumstances is likely to be 
associated with truly excessive morbidity and mortality rates (Cuypers et al., 2000; Goodney 
et al., 2010; May et al., 1997; Starnes et al., 2006).  
5. Conclusion 
Despite the minimal invasive nature of endovascular aneurysm repair, a variety of 
complications do occur with considerable frequency. The patient’s age, anatomy, and 
cardiac and general medical status have a compelling influence on the risk of morbidity and 
mortality. The experience of the operating team is an important factor influencing the risk of 
device-related or procedure-related adverse events. These findings underline the 
importance of adequate training and may help to guide the selection of patients and devices 
for endovascular AAA repair in the future. One cannot overemphasize the importance of 
proper and appropriate patient selection to ensure procedural success.  
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